Susquehanna International Group, LLP Vera Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$34.09 - $46.71 $1.03 Million - $1.41 Million	30,200 Added 58.3%	82,000 $3.62 Million
Q2 2024 Aug 15, 2024	SELL	$33.72 - $48.82 $536,148 - $776,238	-15,900 Reduced 23.49%	51,800 $1.87 Million
Q1 2024 May 07, 2024	BUY	$14.91 - $49.14 $763,392 - $2.52 Million	51,200 Added 310.3%	67,700 $2.92 Million
Q4 2023 Feb 14, 2024	BUY	$9.29 - $16.0 $153,285 - $264,000	16,500 New	16,500 $253,000
Q2 2023 Aug 11, 2023	SELL	$6.11 - $17.83 $116,090 - $338,769	-19,000 Reduced 60.13%	12,600 $202,000
Q1 2023 May 16, 2023	BUY	$5.41 - $18.3 $170,956 - $578,280	31,600 New	31,600 $245,000

184

55.1M

134K

156K

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.15B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.